September 09, 12:00 PM ET / 9:00 AM PT
Webinar: Details provided upon RSVP approval
Rockwell Medical (NASDAQ: RMTI) is building on its strong and successful business in clinical anemia by expanding into the rapidly growing home infusion market. From 2010 to today home infusion therapy has increased over 300% thanks to reduced costs, new technology, and patient preference for home treatment.
Rockwell will begin Phase 2 clinical trials for its home infusion product later this year. Built upon their existing platform, this approach will expedite approval since safety and efficacy have already been established in a clinical setting.
Join us for this webinar to hear from Rockwell Medical CEO, Dr. Russell Ellison and how the company is leveraging their global expertise in treating anemia to become leaders in home infusion therapy.
All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.